PerkinElmer Focuses On Human Health And Environment In China
This article was originally published in PharmAsia News
Executive Summary
PerkinElmer, a global leader in health and industrial sciences, recently announced that it will actively support China's development goals of social, economic and environmental improvement. The company will focus its business on human health and environmental health from 2009. In China, PerkinElmer aims to enhance neonatal health, improve air quality, purify drinking water, increase the effectiveness of recycling energy and its usage capacity, as well as strengthen the safety of airports and roads. The company currently develops and provides key technologies in China, including gene screening and medical imaging, techniques to accelerate drug development, food safety and environmental monitoring systems, as well as powerful digital X-ray for testing pipes and other industrial facilities. (Click here for more - Chinese Language)
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.